ArticleCase reports in hematology2017

Sequential Kinase Inhibition (Idelalisib/Ibrutinib) Induces Clinical Remission in B-Cell Prolymphocytic Leukemia Harboring a 17p Deletion.

H Coelho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.